Testing effectiveness (Phase 2)Ended earlyNCT00211471
What this trial is testing
Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.).
Who this might be right for
Severe Diabetic RetinopathyCentral Retinal Vein OcclusionChronic Inflammation+1 more
Manhattan Eye, Ear & Throat Hospital